AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
OCTREOTIDE
21 registrations across 5 African markets— 14 active
Markets with OCTREOTIDE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| OCTREOTIDE HEXAL 0,1 mg | 🇿🇦South Africa | HEXAL PHARMA (SA) (PTY) LTD | suspended | Aug 2025 |
| OCTREOTIDE HEXAL 0,05 mg | 🇿🇦South Africa | HEXAL PHARMA (SA) (PTY) LTD | suspended | Aug 2025 |
| OCTREOTIDE NEAPOLIS Solution injectable / 0.1 mg/ml | 🇹🇳Tunisia | NEAPOLIS PHARMA | expired | Mar 2021 |
| SANDOSTATINE L.A.R. Poudre pour suspension injectable / 30 mg | 🇹🇳Tunisia | NOVARTIS PHARMA SCHWEIZ AG | expired | Sept 2013 |
| SANDOSTATINE LAR Poudre pour suspension injectable / 20 mg | 🇹🇳Tunisia | NOVARTIS PHARMA SCHWEIZ AG | expired | Sept 2013 |
| SANDOSTATINE Solution injectable / 0.05 mg/ml | 🇹🇳Tunisia | NOVARTIS PHARMA SCHWEIZ AG | expired | Oct 2007 |
| SANDOSTATINE Solution injectable / 0.1 mg/ml | 🇹🇳Tunisia | NOVARTIS PHARMA SCHWEIZ AG | expired | Oct 2007 |
| SANDOSTATIN 0,05 mg/ml INJECTION | 🇿🇦South Africa | Novartis South Africa (Pty) Ltd | active | Jan 1900 |
| SANDOSTATIN 0,1 mg INJECTION | 🇿🇦South Africa | Novartis South Africa (Pty) Ltd | active | Jan 1900 |
| SANDOSTATIN LAR 10 mg | 🇿🇦South Africa | Novartis South Africa (Pty) Ltd | active | Jan 1900 |
| SANDOSTATIN LAR 20 mg | 🇿🇦South Africa | Novartis South Africa (Pty) Ltd | active | Jan 1900 |
| SANDOSTATIN LAR 30 mg | 🇿🇦South Africa | Novartis South Africa (Pty) Ltd | active | Jan 1900 |
| OCTREOTIDE TEVA 10 mg | 🇿🇦South Africa | Teva Pharmaceuticals (Pty) Ltd | active | Jan 1900 |
| OCTREOTIDE TEVA 20 mg | 🇿🇦South Africa | Teva Pharmaceuticals (Pty) Ltd | active | Jan 1900 |
| OCTREOTIDE TEVA 30 mg | 🇿🇦South Africa | Teva Pharmaceuticals (Pty) Ltd | active | Jan 1900 |
| Octride Solution for injection | 🇹🇿Tanzania | Sun Pharmaceutical Industries Ltd | active | — |
| SANDOSTATINE ampoule injectable / 100 mcg / ml | 🇸🇳Senegal | SANDOZ | active | — |
| SANDOSTATINE * SOLUTION INJECTABLE | 🇲🇦Morocco | — | active | — |
| SANDOSTATINE * SOLUTION INJECTABLE | 🇲🇦Morocco | — | active | — |
| SANDOSTATINE ampoule injectable / 50 mcg / ml | 🇸🇳Senegal | SANDOZ | active | — |
| SANDOSTATINE * SOLUTION INJECTABLE | 🇲🇦Morocco | — | active | — |
OCTREOTIDE in Africa — Regulatory Overview
OCTREOTIDE is registered across 5 African markets with 21 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Tunisia, Morocco, Senegal and 1 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 21 registrations, 14 (67%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.